Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod IncfiledCriticalPfizer Prod Inc
Publication of HN2006004322ApublicationCriticalpatent/HN2006004322A/en
Medicines That Contain Protein Lipid Enzymes And Other Medicines
(AREA)
Peptides Or Proteins
(AREA)
Medicinal Preparation
(AREA)
Abstract
La invencion proporciona variantes del péptido PYY3-36 y sus derivados pegilados y composiciones y métodos utiles en el tratamiento de estados modulados por el agonista del receptor Y2 del neuropéptido Y (NPY).The invention provides variants of the peptide PYY3-36 and its pegylated derivatives and compositions and methods useful in treating states modulated by the neuropeptide Y (NPY) receptor Y2 agonist.
HN2006004322A2005-02-042006-02-02
SMALL AGONISTS AND THEIR USES
HN2006004322A
(en)
Compounds derived from 1-oxa-3-azaspiro, antagonists of the neuropeptide y5 receptor y (npy); pharmaceutical composition comprising said compound; and use for the treatment of eating disorders, drinking disorders, obesity, and depression.
Compounds derived from cyanopyridines; pharmaceutical composition; and use for the treatment or inhibition of a protein kinase mediated disorder, such as autoimmune and inflammatory disease.